Boiron Oscillicoccinum in court in Canada – Boiron Canada – Oscillicoccinum.

In March 2012 REO launched a proposed class action against Boiron Canada relating to the marketing of Oscillicoccinum and Oscillicoccinum Children.

The Statement of Claim alleges that, among other things, Boiron breached several consumer protection statues in its marketing of Oscillicoccinum as the product contains virtually none of its purported active ingredient namely Anas Barbarie Hepatis et Cordis extractum (namely the extract of the liver and heart of the Barbary Duck). As a result of those alleged breaches the proposed class members have vastly overpaid for what is in essence a sugar pill.

Tip: @lecanardnoir (Andy Lewis) on Twitter

I must admit, I do like the truth coming out about homeopathy. Hope this case has legs and Boiron products are exposed as having nothing in them.